PMID: 9427177Jan 14, 1998Paper

Aspirin reduces the incidence of second eye NAION: a retrospective study

Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
M J KupersmithF A Warren

Abstract

The objective of this study was to determine if aspirin reduces the incidence of second eye involvement after nonarteritic anterior ischemic optic neuropathy (NAION) in one eye. Records were reviewed of 131 patients who sustained unilateral NAION. Of these, the 33 patients who sustained second eye NAION were compared to those followed for a minimum of 2 years without sustaining a second eye NAION (67). Thirty-one of the 131 patients were excluded because of inadequate follow-up. Except for diabetes (relative risk [RR] 1.43, p = 0.05), the incidence of second eye NAION was independent of gender, age, cup/disk, hypertension, anemia, and migraine. The degree of visual acuity or field dysfunction in the first eye correlated poorly with the acuity (r = 0.28) and field (r = 0.33) loss in the second eye. Aspirin (65-1,300 mg) taken two or more times per week decreased the incidence (17.5% vs. 53.5%) and relative risk (RR = 0.44, p = 0.0002) of second eye AION regardless of the usual risk factors. Even after eliminating those patients who had bilateral disease when first referred, ASA still reduced the incidence of second eye involvement (35% vs. 13%, RR = 0.74, p = 0.01). Aspirin may be an effective means of reducing second eye NAION.

Citations

Sep 10, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Barbara WilhelmUNKNOWN BRAION Study Group
Dec 5, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Barbara GiambeneUgo Menchini
Dec 12, 2012·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Valeria NagyGyorgy Pfliegler
Nov 11, 2010·Current Treatment Options in Neurology·Edward J Atkins
Mar 10, 2004·The Journal of Laboratory and Clinical Medicine·Charles J GlueckNaila Goldenberg
Sep 5, 2002·American Journal of Ophthalmology·Nancy J NewmanUNKNOWN Ischemic Optic Neuropathy Decompression Trial Research Group
Mar 8, 2000·American Journal of Ophthalmology·L N JohnsonR W Madsen
Jun 12, 2002·Pediatric Neurology·Abe M ChutorianMichael Geffner
Mar 10, 2016·Seminars in Ophthalmology·Crandall Peeler, Dean M Cestari
Dec 17, 2009·Survey of Ophthalmology·Edward J AtkinsValérie Biousse
Sep 15, 2007·American Journal of Ophthalmology·Pisit PreechawatValérie Biousse
Nov 18, 2003·Artificial Organs·Eyal Margalit, Srinivas R Sadda
Apr 24, 2001·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·A C Arnold, A G Lee
Apr 20, 2004·Current Opinion in Neurology·Janet C RuckerNancy J Newman
Feb 5, 2013·Neuroepidemiology·Gad Dotan, Amos D Korczyn
Nov 15, 2008·The Neurologist·Katie LuneauValérie Biousse
Aug 30, 2008·Diabetes Care·V Swetha E JeganathanTien Yin Wong
Jul 9, 2009·International Ophthalmology Clinics·Derek W DelMonte, M Tariq Bhatti
Aug 11, 2010·Seminars in Ophthalmology·Alberto Gonzalez-GarciaThomas R Hedges
May 20, 2011·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Neil R Miller
Mar 10, 2020·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Anthony C Arnold
Mar 27, 2020·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Robert A EganGregory P Van Stavern

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.